77 related articles for article (PubMed ID: 7584799)
1. Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up.
Møller LF; Jespersen J
J Cardiovasc Risk; 1995 Jun; 2(3):235-40. PubMed ID: 7584799
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
3. Elevated insulin levels in men: an 11-year follow-up study.
Møller LF; Jespersen J
J Cardiovasc Risk; 1995 Aug; 2(4):339-43. PubMed ID: 8536152
[TBL] [Abstract][Full Text] [Related]
4. Factors related to the development of diabetes during a 20-year follow-up. A prospective study in a homogeneous group of middle-aged men.
Strandberg TE; Salomaa V
Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):239-46. PubMed ID: 11213532
[TBL] [Abstract][Full Text] [Related]
5. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
6. Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians.
Hodge AM; Dowse GK; Collins VR; Alberti KG; Gareeboo H; Tuomilehto J; Zimmet PZ
J Cardiovasc Risk; 1996 Jun; 3(3):263-70. PubMed ID: 8863097
[TBL] [Abstract][Full Text] [Related]
7. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
Shai I; Pischon T; Hu FB; Ascherio A; Rifai N; Rimm EB
Obesity (Silver Spring); 2006 Nov; 14(11):2099-106. PubMed ID: 17135628
[TBL] [Abstract][Full Text] [Related]
8. Trends of lipoprotein variables from childhood to adulthood in offspring of parents with coronary heart disease: the Bogalusa Heart Study.
Youssef AA; Srinivasan SR; Elkasabany A; Chen W; Berenson GS
Metabolism; 2001 Dec; 50(12):1441-6. PubMed ID: 11735090
[TBL] [Abstract][Full Text] [Related]
9. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
[TBL] [Abstract][Full Text] [Related]
10. Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: a 21-year prospective cohort study.
Håheim LL; Tonstad S; Hjermann I; Leren P; Holme I
Scand J Public Health; 2007; 35(1):4-10. PubMed ID: 17366081
[TBL] [Abstract][Full Text] [Related]
11. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
[TBL] [Abstract][Full Text] [Related]
13. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
16. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
Miller M; Zhan M; Havas S
Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
[TBL] [Abstract][Full Text] [Related]
17. Are body mass or insulin resistance independently associated with cardiovascular risk factors in non-diabetic elderly Nigerians?
Ezenwaka CE; Akanji AO; Unwin N; Alberti KG
Diabet Med; 1996 Oct; 13(10):874-81. PubMed ID: 8911781
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study.
Yudkin JS; May M; Elwood P; Yarnell JW; Greenwood R; Davey Smith G;
Diabetologia; 2002 Mar; 45(3):327-36. PubMed ID: 11914737
[TBL] [Abstract][Full Text] [Related]
19. Hematocrit and the risk of coronary heart disease mortality.
Brown DW; Giles WH; Croft JB
Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
Ariza CR; Frati AC; Gómez G; Almazán A
Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]